Literature DB >> 561182

Plant anticancer agents III: Isolation of indole and bisindole alkaloids from Tabernaemontana holstii roots.

D G Kingston, B T Li, F Ionescu.   

Abstract

Certain active antileukemic and cytotoxic fractions prepared from Tabernaemontana holstii roots were investigated, resulting in the isolation of the known indole alkaloids conoduramine, conodurine, coronaridine, gabunine, 19-oxocoronaridine, pericyclivine, perivine, and vobasine. Two new alkaloids were assigned the structures 19-oxoconodurine and 19-(2-oxopropyl)conodurine. Both gabunine and 19-(2-oxopropyl)conodurine showed significant inhibitory activity against P-388 cell culture. All of the alkaloids are reported for the first time from T. holstii; conodurine, conoduramine, gabunine, perivine, and pericyclivine are reported for the first time from any Tabernaemontana species.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561182     DOI: 10.1002/jps.2600660821

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients.

Authors:  Daniel Laryea; Anders Isaksson; Colin W Wright; Rolf Larsson; Peter Nygren
Journal:  Invest New Drugs       Date:  2008-10-14       Impact factor: 3.850

Review 2.  Major Bioactive Alkaloids and Biological Activities of Tabernaemontana Species (Apocynaceae).

Authors:  Clarissa Marcelle Naidoo; Yougasphree Naidoo; Yaser Hassan Dewir; Hosakatte Niranjana Murthy; Salah El-Hendawy; Nasser Al-Suhaibani
Journal:  Plants (Basel)       Date:  2021-02-05

3.  In vitro antibacterial activity of Tabernaemontana alternifolia (Roxb) stem bark aqueous extracts against clinical isolates of methicillin resistant Staphylococcus aureus.

Authors:  Nachiket P Marathe; Mandar H Rasane; Himanshu Kumar; Ankur A Patwardhan; Yogesh S Shouche; Sham S Diwanay
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-09-25       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.